Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV-1 in Healthy Adults Challenged With DENV-3
NCT06799741Phase 2Completed
- Sponsor
- AbViro LLC
- Start
- Jan 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AV-1 in Dengue fever (DENV), sponsored by AbViro LLC. Started Jan 2025; status: completed.
02
Drugs
AV-1
03
Conditions
Dengue fever (DENV)
Beyond the preview
Go deeper on NCT06799741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06799741.